SAN
76.26
-1.73%↓
UCB
250.1
-3.1%↓
SHL.DE
40.38
-0.02%↓
ARGX
620.4
-1.02%↓
PHIA
24.97
-2.19%↓
SAN
76.26
-1.73%↓
UCB
250.1
-3.1%↓
SHL.DE
40.38
-0.02%↓
ARGX
620.4
-1.02%↓
PHIA
24.97
-2.19%↓
SAN
76.26
-1.73%↓
UCB
250.1
-3.1%↓
SHL.DE
40.38
-0.02%↓
ARGX
620.4
-1.02%↓
PHIA
24.97
-2.19%↓
SAN
76.26
-1.73%↓
UCB
250.1
-3.1%↓
SHL.DE
40.38
-0.02%↓
ARGX
620.4
-1.02%↓
PHIA
24.97
-2.19%↓
SAN
76.26
-1.73%↓
UCB
250.1
-3.1%↓
SHL.DE
40.38
-0.02%↓
ARGX
620.4
-1.02%↓
PHIA
24.97
-2.19%↓
24h
Current
Min
109.55
Max
114.3
Income | 250M 902M |
|---|---|
Sales | 63M 5.3B |
Dividend yield | 1.34 |
Profit margin | 16.961 |
Recommendations | Buy |
|---|---|
12 Months Forecast | +31.63% upside |
Dividend yield Sector Avg | 1.34% 2.25% |
|---|---|
Next Earnings | 13 May 2026 |
Market Cap | 98B |
|---|---|
Previous open | 113.77 |
Previous close | 110.05 |
By Acuity
29%
71%
72 / 351 Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
121.15 / 123.55 Support & Resistance
Past performance is not a reliable indicator of future results.
5 Mar 2026, 06:28 UTC
Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings
DJ
Read
13 Nov 2025, 13:40 UTC
Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update
DJ
Read
13 Nov 2025, 06:24 UTC
Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units
DJ
Read
5 Mar 2026, 08:40 UTC
Germany's Merck KGaA Issues Weaker-Than-Expected Guidance -- Market Talk
DJ
Read
5 Mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Ebitda Before Special Items at EUR5.5B-EUR6B
DJ
Read
5 Mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Adj EPS EUR7.10-Adj EPS EUR8
DJ
Read
5 Mar 2026, 06:00 UTC
Analysts Saw Merck KGaA 2025 Ebitda Before Special Items EUR6.1B
DJ
Read
5 Mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Sales EUR20B-EUR21B
DJ
Read
5 Mar 2026, 06:00 UTC
Merck KGaA Sees 2026 Organic Net Sales Ranging From 1% Fall to 2% Rise
DJ
Read
5 Mar 2026, 06:00 UTC
Merck KGaA 2025 Adj EPS EUR8.34
DJ
Read
5 Mar 2026, 06:00 UTC
Analysts Saw Merck KGaA 2025 Net Sales at EUR21.14B
DJ
Read
5 Mar 2026, 06:00 UTC
Merck KGaA Expects Considerable Foreign-Exchange Headwinds in 2026
DJ
Read
5 Mar 2026, 06:00 UTC
Merck KGaA Keeps Dividend at EUR2.20 a Share
DJ
Read
5 Mar 2026, 06:00 UTC
Merck KGaA 2025 After-Tax Profit EUR2.615B
DJ
Read
5 Mar 2026, 06:00 UTC
Germany's Merck KGaA Says Organic Net Sales Grew 3.1% in 2025
DJ
Read
5 Mar 2026, 06:00 UTC
Merck KGaA 2025 Sales EUR21.1B
DJ
Read
5 Mar 2026, 06:00 UTC
Merck KGaA 2025 Ebitda Before Special Items EUR6.11B
DJ
Read
12 Feb 2026, 15:20 UTC
Sanofi Shares Fall After CEO Change -- Update
DJ
Read
20 Jan 2026, 09:54 UTC
DAVOS: Merck KGaA Not in a Hurry for M&A, CEO Says -- Market Talk
DJ
Read
13 Nov 2025, 07:57 UTC
Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk
DJ
Read
13 Nov 2025, 06:00 UTC
Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B
DJ
Read
13 Nov 2025, 06:00 UTC
Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B
DJ
Read
13 Nov 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%
DJ
Read
13 Nov 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%
DJ
Read
13 Nov 2025, 06:00 UTC
Merck KGaA Says Guidance Midpoint Remains Unchanged
DJ
Read
13 Nov 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%
DJ
Read
13 Nov 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Sales Growth of Around 3%
DJ
Read
13 Nov 2025, 06:00 UTC
Merck KGaA 3Q After-Tax Profit EUR898M
DJ
Read
13 Nov 2025, 06:00 UTC
Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors
DJ
Read
13 Nov 2025, 06:00 UTC
Merck KGaA Narrows 2025 View
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 149 EUR 31.63%
High 182 EUR
Low 130 EUR
Based on 7 Wall Street analysts offering 12 month price targets forMerck KGaA - Dist in the last 3 months.
By TipRanks
Buy
7 ratings
5
Buy
2
Hold
0
Sell
Based on 7 analysts giving stock ratings to Merck KGaA - Dist in the past 3 months.
By Trading Central
Short Term
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Neutral Evidence
The bullish and bearish events are balanced.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$